These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 16904375

  • 1. Peptide deformylase as an antibacterial target: a critical assessment.
    Leeds JA, Dean CR.
    Curr Opin Pharmacol; 2006 Oct; 6(5):445-52. PubMed ID: 16904375
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Novel approaches to antimicrobial therapy: peptide deformylase.
    Waller AS, Clements JM.
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):785-92. PubMed ID: 12630299
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a human peptide deformylase: implications for antibacterial drug design.
    Nguyen KT, Hu X, Colton C, Chakrabarti R, Zhu MX, Pei D.
    Biochemistry; 2003 Aug 26; 42(33):9952-8. PubMed ID: 12924944
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structure-activity relationship analysis and therapeutic potential of peptide deformylase inhibitors.
    Boularot A, Giglione C, Artaud I, Meinnel T.
    Curr Opin Investig Drugs; 2004 Aug 26; 5(8):809-22. PubMed ID: 15600237
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
    Yang S, Shi W, Xing D, Zhao Z, Lv F, Yang L, Yang Y, Hu W.
    Eur J Med Chem; 2014 Oct 30; 86():133-52. PubMed ID: 25151577
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Structural basis for the design of antibiotics targeting peptide deformylase.
    Hao B, Gong W, Rajagopalan PT, Zhou Y, Pei D, Chan MK.
    Biochemistry; 1999 Apr 13; 38(15):4712-9. PubMed ID: 10200158
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
    Shi W, Ma H, Duan Y, Aubart K, Fang Y, Zonis R, Yang L, Hu W.
    Bioorg Med Chem Lett; 2011 Feb 01; 21(3):1060-3. PubMed ID: 21185180
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel class of inhibitors of peptide deformylase discovered through high-throughput screening and virtual ligand screening.
    Howard MH, Cenizal T, Gutteridge S, Hanna WS, Tao Y, Totrov M, Wittenbach VA, Zheng YJ.
    J Med Chem; 2004 Dec 30; 47(27):6669-72. PubMed ID: 15615515
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs.
    Chikhi A, Bensegueni A, Boulahrouf A, Bencharif M.
    In Silico Biol; 2006 Dec 30; 6(5):459-66. PubMed ID: 17274774
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
    Jain R, Chen D, White RJ, Patel DV, Yuan Z.
    Curr Med Chem; 2005 Dec 30; 12(14):1607-21. PubMed ID: 16022661
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.